This inventor holds 1 USPTO granted patent. Top assignee: Access Pharmaceuticals, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: **Innovator Howard Callahan in Pharmaceutical Delivery Solutions**
Introduction
Howard Callahan, based in North Richland Hills, TX, is a notable inventor recognized for his significant contribution to pharmaceutical technology. With one patent to his name, he has made strides in enhancing the delivery of active compounds through innovative device design.
Latest Patents
Callahan's patent, titled "Mucoadhesive Erodible Drug Delivery Device for Controlled Administration of Pharmaceuticals and Other Active Compounds," showcases his inventive prowess. This layered pharmaceutical delivery device is designed for the effective administration of pharmaceuticals or other active compounds to mucosal surfaces. The innovative device consists of a water-soluble adhesive layer and a non-adhesive, bioerodable backing layer, which allows for the localized delivery of drugs or can be utilized independently. The ability to regulate the “Residence Time” of the device on the mucosal surface, through modifications to the backing layer, emphasizes its potential in improving therapeutic outcomes.
Career Highlights
Callahan is employed at Access Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical innovations. His role has allowed him to develop practical solutions that aim to enhance drug delivery systems and improve patient outcomes in clinical settings.
Collaborations
Throughout his career, Callahan has collaborated with talented individuals such as Daniel G. Moro and David Peter Nowotnik. These partnerships have likely contributed to the successful development of his patented technologies, fostering a collaborative environment that encourages innovation.
Conclusion
Howard Callahan's contributions to the field of pharmaceutical technology with his innovative drug delivery system highlight the importance of creativity and collaboration in advancing healthcare solutions. His work at Access Pharmaceuticals, Inc. demonstrates a commitment to enhancing patient care through technology, representing a notable achievement in the realm of pharmaceutical innovations.